{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:26:42Z","timestamp":1787344002767,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gout is among the most prevalent arthritides worldwide and is associated with high morbidity, cardiovascular risk, and substantial healthcare burden. Despite effective urate-lowering therapies (ULT), many patients remain undertreated, particularly those with severe or complex disease. Nurse-led gout management has improved outcomes in primary care, but data in multimorbid tertiary center populations are lacking. We aimed to evaluate the effectiveness of a supervised nurse-led gout clinic in achieving and maintaining serum urate (SU) targets in a tertiary hospital cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this observational study at the University Hospital (Inselspital) Bern we report on the performance during May 2023 and Jan 2026 in 69 patients with confirmed gout per a restricted panel of EULAR\/ACR 2015 classification criteria. Patients were assigned to SU targets of \u2264\u2009300 \u00b5mol\/L (group 1: severe gout) or \u2264\u2009360 \u00b5mol\/L (group 2: non-severe gout). An Advanced Practice Nurse (APN) provided education, a rheumatologist provided pharmacological management per 2016 EULAR\/ACR guidelines. SU levels, flare frequency, prophylaxis, and treatment adjustments were monitored, with follow-up at six and twelve months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Group 1 required higher allopurinol doses than group 2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.01). SU targets were achieved in 80% of group 1 regimens and 68% of Group 2. Flare rates and prophylaxis use were comparable. At six\/twelve months follow-up, 62\/67% of group 1 and 85\/88% of group 2 maintained SU targets. Failures were often due to external treatment modifications. No major ULT-related adverse events were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Supervised nurse-led gout management effectively achieves SU targets in this difficult-to-manage cohort. Maintaining SU targets may benefit from shorter follow-up intervals and enhanced education for patients and healthcare providers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-026-00662-8","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:39:26Z","timestamp":1780475966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of a supervised nurse-led outpatient clinic for difficult-to-manage gout patients at a tertiary center"],"prefix":"10.1186","volume":"10","author":[{"given":"Piroska","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Herren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6369-1963","authenticated-orcid":false,"given":"Tobias","family":"Manigold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"27","key":"662_CR1","doi-asserted-by":"publisher","first-page":"e43179","DOI":"10.1097\/MD.0000000000043179","volume":"104","author":"S Alharbi","year":"2025","unstructured":"Alharbi S, Alharthi N, Almuteri D, Jan R, Alsaedi S, Alwakeel A, Alhumaidi N. Knowledge and practice of gout treatment recommendations by primary health care physicians in Saudi Arabia: A cross-sectional study across five different regions. Medicine. 2025;104(27):e43179. https:\/\/doi.org\/10.1097\/MD.0000000000043179.","journal-title":"Medicine"},{"issue":"5","key":"662_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"7","key":"662_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00296-021-04876-6","volume":"41","author":"P Cox","year":"2021","unstructured":"Cox P, Gupta S, Zhao SS, Hughes DM. The incidence and prevalence of cardiovascular diseases in gout: A systematic review and meta-analysis. Rheumatol Int. 2021;41(7):1209\u201319. https:\/\/doi.org\/10.1007\/s00296-021-04876-6.","journal-title":"Rheumatol Int"},{"issue":"1","key":"662_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"N Dalbeth","year":"2019","unstructured":"Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, Stamp LK. Gout. Nat Reviews Disease Primers. 2019;5(1):69. https:\/\/doi.org\/10.1038\/s41572-019-0115-y.","journal-title":"Nat Reviews Disease Primers"},{"issue":"10287","key":"662_CR5","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout Lancet. 2021;397(10287):1843\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9.","journal-title":"Gout Lancet"},{"issue":"10156","key":"662_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","volume":"392","author":"M Doherty","year":"2018","unstructured":"Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, Barclay C, Doherty S, Duley L, Hatton R, Rees F, Stevenson M, Zhang W. Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: A randomised controlled trial. Lancet. 2018;392(10156):1403\u201312. https:\/\/doi.org\/10.1016\/S0140-6736(18)32158-5.","journal-title":"Lancet"},{"issue":"3","key":"662_CR7","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/S2665-9913(23)00338-7","volume":"6","author":"LD Ferguson","year":"2024","unstructured":"Ferguson LD, Molenberghs G, Verbeke G, Rahimi K, Rao S, McInnes IB, McMurray JJV, Sattar N, Conrad N. Gout and incidence of 12 cardiovascular diseases: A case-control study including 152\u2008663 individuals with gout and 709\u2008981 matched controls. Lancet Rheumatol. 2024;6(3):e156\u201367. https:\/\/doi.org\/10.1016\/S2665-9913(23)00338-7.","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"662_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/rheumatology\/kez333","volume":"59","author":"A Fuller","year":"2020","unstructured":"Fuller A, Jenkins W, Doherty M, Abhishek A. Nurse-led care is preferred over GP-led care of gout and improves gout outcomes: Results of Nottingham Gout Treatment Trial follow-up study. Rheumatology. 2020;59(3):575\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kez333.","journal-title":"Rheumatology"},{"issue":"7","key":"662_CR9","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/acr.25009","volume":"75","author":"N Hammam","year":"2023","unstructured":"Hammam N, Li J, Kay J, Izadi Z, Yazdany J, Schmajuk G. Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry. Arthritis Care Res. 2023;75(7):1544\u201352. https:\/\/doi.org\/10.1002\/acr.25009.","journal-title":"Arthritis Care Res"},{"key":"662_CR10","unstructured":"Herren R, B\u00fcrgisser N, Mongin D, Courvoisier DS, Lauper K, Manigold T. Gichtsprechstunde und Register: Neue Wege zur Optimierung des Gichtmanagements. Rheuma Schweiz. 2025;3."},{"issue":"1","key":"662_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","volume":"75","author":"C-F Kuo","year":"2016","unstructured":"Kuo C-F, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: Case-control study. Ann Rheum Dis. 2016;75(1):210\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206410.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"662_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jbspin.2018.10.008","volume":"86","author":"ZP Latif","year":"2019","unstructured":"Latif ZP, Nakafero G, Jenkins W, Doherty M, Abhishek A. Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care. Joint Bone Spine. 2019;86(3):357\u201362. https:\/\/doi.org\/10.1016\/j.jbspin.2018.10.008.","journal-title":"Joint Bone Spine"},{"key":"662_CR13","doi-asserted-by":"publisher","first-page":"117289","DOI":"10.1016\/j.bios.2025.117289","volume":"277","author":"C Moonla","year":"2025","unstructured":"Moonla C, Khan MI, Akgonullu S, Saha T, Wang J. Touch-based uric acid sweat biosensor towards personal health and nutrition. Biosens Bioelectron. 2025;277:117289. https:\/\/doi.org\/10.1016\/j.bios.2025.117289.","journal-title":"Biosens Bioelectron"},{"issue":"10","key":"662_CR14","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TLTA, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJEM, Liot\u00e9 F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche A-K, Taylor WJ. 2015 Gout classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789\u201398. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208237.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"662_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/rheumatology\/key002","volume":"58","author":"T Pascart","year":"2019","unstructured":"Pascart T, Liot\u00e9 F. Gout: State of the art after a decade of developments. Rheumatology. 2019;58(1):27\u201344. https:\/\/doi.org\/10.1093\/rheumatology\/key002.","journal-title":"Rheumatology"},{"issue":"9","key":"662_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/1756-185X.13855","volume":"23","author":"KF Phang","year":"2020","unstructured":"Phang KF, Santosa A, Low BPL, Tan PSH, Khong ZW, Lim AYN, Teng GG, Tay SH. A nurse-led, rheumatologist-assisted telemedicine intervention for dose escalation of urate-lowering therapy in gout. Int J Rheum Dis. 2020;23(9):1136\u201344. https:\/\/doi.org\/10.1111\/1756-185X.13855.","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"662_CR17","doi-asserted-by":"publisher","first-page":"e004179","DOI":"10.1136\/rmdopen-2024-004179","volume":"10","author":"C Rasmussen","year":"2024","unstructured":"Rasmussen C, Larsen JW, Christensen HM, Larsen MB, Thomsen AM, Leishmann T, Kragh J, Nielsen GL. Optimising gout treatment: Insights from a nurse-led cohort study. RMD Open. 2024;10(2):e004179. https:\/\/doi.org\/10.1136\/rmdopen-2024-004179.","journal-title":"RMD Open"},{"issue":"1","key":"662_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liot\u00e9 F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Bardin T. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"662_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1093\/rheumatology\/kex521","volume":"57","author":"E Roddy","year":"2018","unstructured":"Roddy E, Packham J, Obrenovic K, Rivett A, Ledingham JM. Management of gout by UK rheumatologists: A British Society for Rheumatology national audit. Rheumatology. 2018;57(5):826\u201330. https:\/\/doi.org\/10.1093\/rheumatology\/kex521.","journal-title":"Rheumatology"},{"issue":"11","key":"662_CR20","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2165\/11592290-000000000-00000","volume":"71","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger N. Difficult-to-treat gouty arthritis: A disease warranting better management. Drugs. 2011;71(11):1413\u201339. https:\/\/doi.org\/10.2165\/11592290-000000000-00000.","journal-title":"Drugs"},{"issue":"3","key":"662_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/annrheumdis-2017-212063","volume":"77","author":"V Sigurdardottir","year":"2018","unstructured":"Sigurdardottir V, Drivelegka P, Sv\u00e4rd A, Jacobsson LTH, Dehlin M. Work disability in gout: A population-based case-control study. Ann Rheum Dis. 2018;77(3):399\u2013404. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212063.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"662_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12891-017-1573-6","volume":"18","author":"JA Singh","year":"2017","unstructured":"Singh JA, Bharat A, Khanna D, Aquino-Beaton C, Persselin JE, Duffy E, Elashoff D, Khanna PP. Health care utilization in patients with gout: A prospective multicenter cohort study. BMC Musculoskelet Disord. 2017;18(1):233. https:\/\/doi.org\/10.1186\/s12891-017-1573-6.","journal-title":"BMC Musculoskelet Disord"},{"key":"662_CR23","doi-asserted-by":"publisher","first-page":"215013192311673","DOI":"10.1177\/21501319231167379","volume":"14","author":"SS Sutton","year":"2023","unstructured":"Sutton SS, Magagnoli J, Cummings TH, Hardin JW. Odds of Achieving Target Serum Uric Acid Levels Among Gout Patients: The Role of Rurality in Outcomes and Treatment Adherence. J Prim care community health. 2023;14:21501319231167379. https:\/\/doi.org\/10.1177\/21501319231167379.","journal-title":"J Prim care community health"},{"key":"662_CR24","doi-asserted-by":"publisher","first-page":"152782","DOI":"10.1016\/j.semarthrit.2025.152782","volume":"74","author":"J van der Ven","year":"2025","unstructured":"van der Ven J, Flendrie M, van Dijck F, Wientjes MHM, van Herwaarden N, Riches PL, van den Bemt BJF, Verhoef LM. Cost-effectiveness of nurse-led home monitoring of serum urate for gout patients starting with urate-lowering therapy in secondary care: A modeling study. Semin Arthritis Rheum. 2025;74:152782. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152782.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"662_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47(6):626\u201333. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5.","journal-title":"Med Care"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00662-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T20:02:12Z","timestamp":1787342532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00662-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["662"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00662-8","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave informed consent in accordance with the Declaration of Helsinki and following the Swiss Humanforschungsgesetz. The study was approved by the Cantonal Ethics Committee Bern (No. 2025\u2009\u2212\u200901880).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"64"}}